title: Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates.
abstract: We examined the potential for "double grafts," i.e., grafts from two donors in each recipient, to enhance the total number of ventral mesencephalic dopamine neurons that survive grafting in adult African green monkeys. Because dopamine cell survival in grafts represents a small percentage of the total number of neurons grafted, several human clinical trials recently have employed grafts of tissue from multiple donors (e.g., from two to eight embryos per host recipient) in attempts to increase the total number of dopamine neurons that survive in grafts. Presumably, this is intended to elevate dopamine levels by providing more dopamine neurons to the damaged brain to alleviate the symptoms of parkinsonism. While well-developed grafts with several thousand dopamine neurons were found in most recipient animals, we observed a reduced total number of tyrosine hydroxylase positive neurons in the grafts in spite of the presence of some double grafts that were larger than normal. The overall growth of the grafts was impressive; some grafts were so large that they spanned the full dorsoventral extent of the caudate nucleus, probably reflecting the fact that twice as much tissue was implanted in each drop site in comparison to our standard protocol. However, some animals revealed atypical patterns of neurite outgrowth that appeared limited to the grafted tissue, and at least one monkey revealed "amorphous" grafts generally lacking in cellular structure, which suggests a possible rejection phenomenon. These findings raise questions about the use of multiple donors and suggest that the likelihood of rejection and/or cell death may be enhanced, which is of potential importance in the design of grafting strategies for clinical applications.
authors.affiliation: Department of Neuroscience, The Chicago Medical School, N. Chicago, IL 60064, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Sladek
authors.forename: T J
authors.initials: TJ
authors.lastname: Collier
authors.forename: J D
authors.initials: JD
authors.lastname: Elsworth
authors.forename: R H
authors.initials: RH
authors.lastname: Roth
authors.forename: J R
authors.initials: JR
authors.lastname: Taylor
authors.forename: D E
authors.initials: DE
authors.lastname: Redmond
mesh_terms: D000818:Animals; D016380:Brain Tissue Transplantation / Q000379:methods* / Q000473:pathology* / Q000502:physiology; D002452:Cell Count; D002470:Cell Survival; D002522:Chlorocebus aethiops; D004298:Dopamine / Q000378:metabolism; D016332:Fetal Tissue Transplantation / Q000379:methods* / Q000473:pathology* / Q000502:physiology; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D014019:Tissue Donors
chemical_list: D004298:Dopamine